Melisachew M Yeshi (@Mele_path) header
Melisachew M Yeshi (@Mele_path) profile picture

MD

Addis Ababa, Ethiopia
Joined October 2014
Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)Photo by Melisachew M Yeshi (@Mele_path)
Melisachew M Yeshi retweeted
Check out the multi-institutional study led by Drs. Jennifer Nguyen @patholojenMD and Ankur Sangoi @slusagar! ▶️ link.springer.com/article/10… #GUpath #MolPath
11
52
1,326
Melisachew M Yeshi retweeted
NOT a germinal center. Beware high-grade invasive carcinoma with the (no longer recognized) medullary pattern. Lymphoepithelioma-like carcinoma is another somewhat quaint term used on occasion. #breastpath
1
8
29
1,548
Melisachew M Yeshi retweeted
When large nests of tumor surround a completely normal duct, they are much more likely to be invasive cancer or lymphovascular invasion than DCIS. A useful pattern to remember on a biopsy #breastpath
1
28
2
87
3,427
Melisachew M Yeshi retweeted
Sorry for the long silence. This is a quick in-house case I had to share. Breast mass, 2 cm. High grade, central fibrosis, lymphoid infiltrate, ER/PR/HER2 negative. Classic TNBC. Correct? Incorrect. History of melanoma, discovered by chance, not mentioned anywhere in the pathology requisition, casually buried in a random note. How scared should we be? How often should we work-up triple-negative tumors in search of some odd metastatic lesion? How many of you would have worried about this and investigated it further in the absence of history? I certainly wouldn't have. Good luck staying safe and cautious without spiraling down into the abyss of obsession and paranoia. IHC: Melan-A #melanoma #breastcancer #breastpath @washupathedu @washu_pathology
4
19
1
67
4,043
#publicationalert #gupath Check out our review focusing on practice-changing updates in bladder and prostate, read and share! @LiangChengMD @Shounak_Gupta @Human_Pathology 🔗 sciencedirect.com/science/ar…
2
29
1
81
11,646
Melisachew M Yeshi retweeted
Congratulations to @UPMCPathology's Dr. Liron Pantanowitz (@PathPro), Dr. Hooman Rashidi, and Dr. Matthew Hanna on their recent series presented by @TheUSCAP and @ModernPathology!
1
7
22
2,004
Melisachew M Yeshi retweeted
🔬Diagnosis & Bite sized Pearl | Previous Case! 🔱 The Rise of SCC in a MATURE CYSTIC TERATOMA #BSTpath #Pathresidents #PathTwitter #pathx @Pathologists @Pathology_mcqs @AceMyPath
A middle aged | 👩 🔬DiaGNosiS? 🗺 siTe?
8
1
53
4,419
Melisachew M Yeshi retweeted
A teaching point from our Editors. How do you distinguish between intrapancreatic bile duct carcinoma and pancreatic ductal carcinoma? @samuel_reis
1
12
21
1,314
Melisachew M Yeshi retweeted
In my training, I heard two different thought processes regarding how to approach signing out cases. I would like to hear from experienced pathologists which one they follow: Do you prefer knowing the pt’s hx before looking at the slide, or no hx?#PathX #PathTwitter #Pathology
74%Hx, better DD,less time
26%No Hx, no bias
53 votes • Final results
8
3
3
12
5,242
Like most things there is no one right answer but I like to see H&E without bias first.
In my training, I heard two different thought processes regarding how to approach signing out cases. I would like to hear from experienced pathologists which one they follow: Do you prefer knowing the pt’s hx before looking at the slide, or no hx?#PathX #PathTwitter #Pathology
74%Hx, better DD,less time
26%No Hx, no bias
53 votes • Final results
6
1
1
11
3,955
Support my hustle with just a Retweet 🙏🏾
72
1,650
29
3,541
163,606
Melisachew M Yeshi retweeted
Animated tram truck appearance of papillary thyroid carcinoma, tall cell variant
10
107
13
502
Melisachew M Yeshi retweeted
🍏 – at Chicago, IL
5
8
1
69
2,974
Melisachew M Yeshi retweeted
FNA of a 2 cm round well-circumscribed mass in the pancreatic tail. What is your interpretation? A) Benign B) Low-grade neoplasm C) Suspicious D) Malignant #GIPath #PathTwitter #Pathology #CytoPath
4
17
65
5,936
A study finds that women of Black or African ancestry have fewer cancer-associated genetic mutations than White women but less access to genetic counseling. Our latest edition of CytoSource explains more: acsjournals.onlinelibrary.wi… @bfaquin
3
5
314
Melisachew M Yeshi retweeted
🎆 Happy new year 🎆 📸Thyroid. papillary carcinoma. #pathart
8
37
904
Melisachew M Yeshi retweeted
✅Suspicious for malignancy, Acinic Cell Carcinoma polygonal cells, dispersed or loosely cohesive adhere to capillary meshwork nuclei are uniform, round, and eccentric distinct nucleolus cytoplasm is abundant & vacuolated with zymogen granules background is frothy with stripped nuclei absence of mitotic activity, necrosis 🔬learn.mghpathology.org/index… #Pathology #CytoPath #CytoPathology #PathTwitter
10
45
1,473
Melisachew M Yeshi retweeted
One of my favorite things: When one of my colleagues drops by to show me a case . . . At the end of the interaction, I always say thank you . . . and mean it. I'm grateful for the opportunity to learn from challenging cases & to support an environment conducive to learning.
10
11
3
80
5,117
Melisachew M Yeshi retweeted
My jaw dropped when I saw my account mentioned in this paper! 🥰🙏
To all who celebrate 🎊, Merry Christmas🎄. Huge #ChristmasEve reading recommendation: 🌟 editorial recapping #thebest of #UEGweek 2024 ✨ journey of three participants through excellent scientific and extra-scientific programme by @my_ueg @maloehr1 doi.org/10.1002/ueg2.12746
6
5
68
16,125